ImmunoTargets and therapy

Keyphrases

Publications

volume 12, 2023

Sruthi S Nair, Saiju Jacob
Novel Immunotherapies for Myasthenia Gravis. ImmunoTargets and therapy 12 (2023)
Jiangpeng Zhu, Guangyao Li, Zhengjun Zhang, Yandong Wang
A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX. ImmunoTargets and therapy 12 (2023)
Azzam A Maghazachi
Globoid Cell Leukodystrophy (Krabbe Disease): An Update. ImmunoTargets and therapy 12 (2023)
Simmi Wiggins, Noah A Levit
Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]. ImmunoTargets and therapy 12 (2023)
Xue-Qian Cai, Qian Huang, Tian-Ping Zhang
The Methylation in B7-H4 and BTLA Genes are Associated with the Risk of Pulmonary Tuberculosis. ImmunoTargets and therapy 12 (2023)
Najwa A Mhmoud
Association of Toll-like Receptors 1, 2, 4, 6, 8, 9 and 10 Genes Polymorphisms and Susceptibility to Pulmonary Tuberculosis in Sudanese Patients. ImmunoTargets and therapy 12 (2023)
Khalid Siddiqui, Shaik Sarfaraz Nawaz
Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. ImmunoTargets and therapy 12 (2023)
Chiara Alfia Ferrara, Gaetano La Rocca, Giuseppe Ielo, Alessandro Libra, Gianluca Sambataro
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives. ImmunoTargets and therapy 12 (2023)
Jiqian Jiang, Yan Wang, Dan Liu, Xiaoyu Wang, Yingqiao Zhu, Juan Tong, Erling Chen, Lei Xue, Na Zhao, Tingting Liang, Chang-Cheng Zheng
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes. ImmunoTargets and therapy 12 (2023)
Xue-Ping Wang, Zhi-Xing Guo, Xingping Wu, Da Chen, Fang Wang, Lewei Yang, Min Luo, Shaocong Wu, Chuan Yang, Lamei Huang, Liwu Fu
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer. ImmunoTargets and therapy 12 (2023)
Xue-Ping Wang, Zhi-Xing Guo, Xingping Wu, Da Chen, Fang Wang, Lewei Yang, Min Luo, Shaocong Wu, Chuan Yang, Lamei Huang, Liwu Fu
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer. ImmunoTargets and therapy 12 (2023)
Jiangpeng Zhu, Guangyao Li, Zhengjun Zhang, Yandong Wang
A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX. ImmunoTargets and therapy 12 (2023)
Junfeng Zhao, Shaoyu Hao, Ying Li, Xiaoman Liu, Zhaoxuan Liu, Chunhui Zheng, Dan Han
Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis. ImmunoTargets and therapy 12 (2023)

volume 11, 2022

Guilherme Renke, Thomaz Baesso, Raphaela Paes, Aline Renke
β-Glucan "Trained Immunity" Immunomodulatory Properties Potentiate Tissue Wound Management and Accelerate Fitness Recover. ImmunoTargets and therapy 11 (2022)
Jessica D Macdougall, Kevin O Thomas, Onyinye I Iweala
The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome. ImmunoTargets and therapy 11 (2022)
Adam Yuh Lin, Joseph Michael Schnitter, Leo I Gordon
Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma. ImmunoTargets and therapy 11 (2022)
Long G Wang, Luxi Wang
Current Strategies in Treating Cytokine Release Syndrome Triggered by Coronavirus SARS-CoV-2. ImmunoTargets and therapy 11 (2022)
Angelina Labib, Teresa Ju, Ashley Vander Does, Gil Yosipovitch
Immunotargets and Therapy for Prurigo Nodularis. ImmunoTargets and therapy 11 (2022)
Muhammet Celik, Brian Fuehrlein
A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects. ImmunoTargets and therapy 11 (2022)

volume 10, 2021

Laura C Arneson, Kristen J Carroll, Eric M Ruderman
Bruton's Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis. ImmunoTargets and therapy 10 (2021)
John W Greiner, Y Maurice Morillon, Jeffrey Schlom
NHS-IL12, a Tumor-Targeting Immunocytokine. ImmunoTargets and therapy 10 (2021)
Poonkiat Suchonwanit, Chaninan Kositkuljorn, Cherrin Pomsoong
Alopecia Areata: An Autoimmune Disease of Multiple Players. ImmunoTargets and therapy 10 (2021)
Bettina Wedi, Stephan Traidl
Anti-IgE for the Treatment of Chronic Urticaria. ImmunoTargets and therapy 10 (2021)
Nikesh N Shah, Lubomir Sokol
Targeting CD22 for the Treatment of B-Cell Malignancies. ImmunoTargets and therapy 10 (2021)
Joshua F E Koenig, Kelly Bruton, Allyssa Phelps, Emily Grydziuszko, Rodrigo Jiménez-Saiz, Manel Jordana
Memory Generation and Re-Activation in Food Allergy. ImmunoTargets and therapy 10 (2021)
Yang Yang, Md Sahidul Islam, Yuanjia Hu, Xin Chen
TNFR2: Role in Cancer Immunology and Immunotherapy. ImmunoTargets and therapy 10 (2021)
Hanley N Abramson
Immunotherapy of Multiple Myeloma: Promise and Challenges. ImmunoTargets and therapy 10 (2021)
Friederike Held, Ana-Katharina Klein, Achim Berthele
Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New? ImmunoTargets and therapy 10 (2021)
Fabiola Atzeni, Antonio Carriero, Laura Boccassini, Salvatore D'Angelo
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. ImmunoTargets and therapy 10 (2021)
Sofiane Fodil, Djillali Annane
Complement Inhibition and COVID-19: The Story so Far. ImmunoTargets and therapy 10 (2021)
Jessica D Macdougall, A Wesley Burks, Edwin H Kim
Current Insights into Immunotherapy Approaches for Food Allergy. ImmunoTargets and therapy 10 (2021)
Kaja Kasarello, Dagmara Mirowska-Guzel
Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era. ImmunoTargets and therapy 10 (2021)
Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, Silvia Novello
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? ImmunoTargets and therapy 10 (2021)
Sarah Unterberger, Kevin A Davies, Srinivasa Bhargav Rambhatla, Sandra M Sacre
Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology. ImmunoTargets and therapy 10 (2021)
Angela Gomez-Arboledas, Munjal M Acharya, Andrea J Tenner
The Role of Complement in Synaptic Pruning and Neurodegeneration. ImmunoTargets and therapy 10 (2021)
Priscila O Barros, Tamara K Berthoud, Nawaf Aloufi, Jonathan B Angel
Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent. ImmunoTargets and therapy 10 (2021)
Bárbara Kong-Cardoso, Amélia Ribeiro, Rita Aguiar, Helena Pite, Mario Morais-Almeida
Understanding and Managing Severe Asthma in the Context of COVID-19. ImmunoTargets and therapy 10 (2021)
Surojit Karmakar, Pradipta Pal, Girdhari Lal
Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies. ImmunoTargets and therapy 10 (2021)
Ning Xu, Benjamin Tse, Lu Yang, Tiffany C Y Tang, Michelle Haber, Kenneth Micklethwaite, Alla Dolnikov
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy. ImmunoTargets and therapy 10 (2021)
Mika Casey, Kyohei Nakamura
The Cancer-Immunity Cycle in Multiple Myeloma. ImmunoTargets and therapy 10 (2021)
Michael Levy, Maureen A Mealy
B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20. ImmunoTargets and therapy 10 (2021)
Hamza Hashmi, Muhammad Husnain, Ali Khan, Saad Z Usmani
CD38-Directed Therapies for Management of Multiple Myeloma. ImmunoTargets and therapy 10 (2021)
Marco Tagliamento, Elisa Agostinetto, Roberto Borea, Mariana Brandão, Francesca Poggio, Alfredo Addeo, Matteo Lambertini
VISTA: A Promising Target for Cancer Immunotherapy? ImmunoTargets and therapy 10 (2021)
Reyisa Bughda, Paraskevi Dimou, Reena R D'Souza, Astero Klampatsa
Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma. ImmunoTargets and therapy 10 (2021)
Shouling Zhang, Scott Sicherer, M Cecilia Berin, Amanda Agyemang
Pathophysiology of Non-IgE-Mediated Food Allergy. ImmunoTargets and therapy 10 (2021)
Megan Mosca, Julie Hong, Edward Hadeler, Marwa Hakimi, Wilson Liao, Tina Bhutani
The Role of IL-17 Cytokines in Psoriasis. ImmunoTargets and therapy 10 (2021)
Fumio Takaiwa
Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches. ImmunoTargets and therapy 10 (2021)
Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, Fabiola Atzeni, Sara Bongiovanni, Piercarlo Sarzi-Puttini
Cannabis and Autoimmunity: Possible Mechanisms of Action. ImmunoTargets and therapy 10 (2021)
Amal Hasan, Ebaa Al-Ozairi, Zahraa Al-Baqsumi, Rasheed Ahmad, Fahd Al-Mulla
Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. ImmunoTargets and therapy 10 (2021)

volume 9, 2021

Melissa Maria Johanna van Gool, Marjolein van Egmond
IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity. ImmunoTargets and therapy 9 (2021)